Rx (Prescription Medicine)
USD $ 30.00
Natdac 60mg Tablet 是一种含有达卡利那韦（Daclatasvir）作为活性成分的药物。达卡利那韦是一种强效抗病毒药物，用于治疗慢性乙型肝炎病毒（HCV）感染。它通过抑制NS5A蛋白起作用，而NS5A蛋白对乙型肝炎病毒在肝细胞内的复制至关重要。通过阻断该蛋白，达卡利那韦能够有效阻止病毒的增殖，使机体的免疫系统得以清除感染。
Natdac 60mg Tablet 适用于与其他抗病毒药物联合使用，用于治疗慢性乙型肝炎病毒（HCV）1、2、3、4型基因型的成人患者。剂量和治疗时长将由医疗专业人员根据患者的具体基因型、肝功能以及既往治疗史等因素确定。通常每天口服一次。
常见的不良反应可能包括头痛、疲劳、恶心和失眠。严重不良反应虽罕见但可能发生。如出现任何不寻常或严重的症状，患者应立即向医生报告。储存方法通常为将药片置于室温、避光、避潮，并置于儿童不易触及的地方。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule |
其他品牌的 Daclatasvir 60 Mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
